Vimarsana
Biggest News Aggregation in the World

Page 8 - Systemic Lupus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Lupus Today - Breaking & Trending Today

What ophthalmologists want patients to know about eye health: AMA - Vimarsana News

What ophthalmologists want patients to know about eye health: AMA

Here are 14 things ophthalmologists want their patients to know about maintaining their eye health, according a May 12 article on the American Medical Association website.

Advocates make the case for change in lupus care - Vimarsana News

Advocates make the case for change in lupus care

Improvements with impact: In recognition of World Lupus Day, let’s commit to raise expectations in care and improve the future for people living with lupus.

Vitamin D Levels Can Influence Risk of Miscarriage, Premature Delivery in Women with Lupus - Vimarsana News

Vitamin D Levels Can Influence Risk of Miscarriage, Premature Delivery in Women with Lupus

An analysis of more than 250 pregnancies among women with SLE from the Hopkins Lupus Cohort provides insight into risk of adverse pregnancy outcomes based on serum 25-hydroxy vitamin D levels using real-world data.

BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases - Vimarsana News

BioSenic receives key European patent from EPO, for further therapeutic development in cancer, infectious and immune diseases

INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds with unique advantages BioSenic’s new formulation lowers the dosage of... | April 18, 2023

BioSenic provides Financial Update and Financial Calendar 2023 - Vimarsana News

BioSenic provides Financial Update and Financial Calendar 2023

INSIDE INFORMATION Mont-Saint-Guibert, Belgium, March 31, 2023, 7am CET - BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases